department banner
Daniel H. Teitelbaum, M.D.
Professor of Surgery

C.S. Mott Children's Hospital

Current Funding:

  1. Funding Institution: National Institutes of Health 2R01AI-44076-06
    Grant Title: TPN-Induced Changes in Intestinal Intraepithelial Lymphocytes
    Percent Effort: 40%
    Principal Investigator : Daniel H. Teitelbaum
    Dates and funding amount: 07/01/2004 to 06/30/2009
    Direct costs: $1,000,000.
  2. Funding Institution: National Institutes of Health
    Grant Title: Mechanisms of Adaptation in Human Short Bowel Syndrome
    Percent Effort: 2%
    Principal Investigator : Thomas R. Ziegler
    Dates and funding amount: 07/01/2004 to 06/30/2006
    Role: Data Safety Monitor

Completed:

Funding Institution: National Institutes of Health
Grant Title: The Role of the NK1-T Lymphocyte in the Aging Mouse.
Percent Effort: 30%
Principal Investigator : Daniel H. Teitelbaum
RO3 AG15675-01
Dates of participation: 4/98 to 3/00;
Direct Cost: $50,000.
Funding Institution: Food and Drug Administration
Grant Title: Prevention of TPN-Cholestasis with Cholecystokinin,
Percent Effort: 15%
Principal Investigator : Daniel H. Teitelbaum
FD-R-001449-01
Dates of participation: 9/97 to 8/02;
Direct costs: $524,410.
Funding Institution: Maternal and Child Health EMSC – NDDP Program 1U03 MC 00003-01
Grant Title: EMSC Network Development Demonstration Project
Percent Effort: 10%
Principal Investigator : Ronald Maio
Candidate’s role on the grant: Co-Investigator
Dates of participation: 10/01/01 to 10/30/02
Direct costs: $1,762,918
Funding Institution: National Institutes of Health
Grant Title: TPN-Induced Changes in Intestinal Intraepithelial Lymphocytes.
Percent Effort: 50%
Principal Investigator : Daniel H. Teitelbaum
1 R29 AI44076-01.
Dates and funding amount: 7/1999 to 6/2004;
Direct costs: $350,000.